# FCA Health Innovations III QP, LP — Form D

FCA Health Innovations III QP, LP of NASHVILLE, TN, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2026-05-15. The offering totals $175.0M, of which $49.9M was reported sold. Industry: Pooled Investment Fund.

## Offering

- Filed: 2026-05-15
- Form: D
- Accession: 0002134121-26-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b,3C,3C.7
- Total offering: $175.0M
- Amount sold: $49.9M
- Remaining: $125.1M
- Minimum investment: $100K
- Investors: 85
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-584293

## Issuer

- Name: FCA Health Innovations III QP, LP
- CIK: 0002134121
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Address: 30 BURTON HILLS BLVD. SUITE 230, NASHVILLE, TN, 37215
- Phone: (615) 498-6614

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Andrew J. Bouldin | Related Person | Nashville, TN |
| Charles W. Johnson | Related Person | Nashville, TN |
| Whitney H. Kalb | Related Person | Nashville, TN |
| Matthew A. King | Related Person | Nashville, TN |

## More

- [CIK 2134121 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2134121&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002134121-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.